Webdisclosure.com

Search

UCB (EBR:UCB) UCB Media Room: Transparency Notification

Directive transparence : information réglementée

12/12/2019 20:00
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6HnxeefVm-2FlNugAwKpD5t4i-2B9BedIG-2FIp61nSwTg-2FJj4u-2BxNptffD= -2Fl4CwKsA8qBChLMjapIAuGLEV6MZc3Bcid3Wmj_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4= re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1Ts= ABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh-2B4k9FqtM3JLmm2iLomIaFDP9298zyz9FUG7L0= nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i491Wf3GhD7u42hob6ONMdTEh3GK-2BqZxOHOEzF5= 5UcH-2Fy3EzLKNymUJ7evWgcQEfdMnBHn9A-2BCCDFMnPW3q07t0eiEdDNBB-2Fa-2BNauYm2AM= t5C5B-2BorOIOFySlFPq6VucyaBNMO2w93j2ocNckXYE5ZLN4-2BpIg-3D ** Transparency notifications BlackRock, Inc ------------------------------------------------------------ =C2=B7 Notifications referring to situation on 6 and 11 December 2019 =C2=B7 Threshold crossed: 5% =C2=B7 Latest holding: 5.11%=C2=A0 Brussels (Belgium), 12 December =C2=A02019 =E2=80=93 20:00 (CET) =E2=80=93 = regulated information 1.=C2=A0=C2=A0Summary of the notifications Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large = shareholdings, UCB SA/NV announces that it has received 2 transparency noti= fications from BlackRock, Inc. (having its registered office at 55 East 52n= d Street, New York, NY, 10055, U.S.A.), dated 9 and 12 December 2019 respec= tively. In the first notification, BlackRock, Inc., has notified that, following a = disposal of UCB shares with voting rights by its affiliates, its holding of= UCB shares with voting rights has decreased and has crossed downwards the = 5% threshold on 6 December 2019.=C2=A0 On 6 December 2019, BlackRock, Inc. (taking into account the holding of its= affiliates) Inc. owned 9 639 270 UCB shares with voting rights (versus 9 7= 53 879 shares in its previous notification), representing 4.96% of the tota= l number of shares issued by the company (194 505 658) (versus 5.01% in its= previous notification), as well as 231 644 equivalent financial instrument= s (versus 216 713 in its previous notification) representing 0.12% of the t= otal number of shares issued by the company (versus 0.11% in its previous n= otification).=C2=A0 In the second notification, BlackRock, Inc., has notified that, following a= n acquisition of UCB shares with voting rights by its affiliates, its holdi= ng of UCB shares with voting rights has increased and has crossed the 5% th= reshold on 11 December 2019.=C2=A0 On 11 December 2019, BlackRock, Inc. (taking into account the holding of it= s affiliates) owned=C2=A0 9 735 421 UCB shares with voting rights, represen= ting 5.01% of the total number of shares issued by the company, as well as = 198 312 equivalent financial instruments, representing 0.10% of the total n= umber of shares issued by the company. 2.=C2=A0=C2=A0Further information=C2=A0 This press release and the detailed transparency notifications are availabl= e on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.c= t.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0= k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM= 8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZf= LoWbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh-2B4k9FqtM3JLmm2iLomIaFDP929= 8zyz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i491Wf3Lt2OY8Wl9R1MvksSe1jwDka= DMhfkAvO5Nz09Yi-2FxeekidIsCUNeOWNl4PWbp8wu-2BDzBtnhbxk4H49uTgVTy5PQJpx0dRSS= xttnbRSE2mxs0XvcEQEEVclPl0kzGpalYMFyLMpbEHUsxZVHEwSyFpYM-3D . An updated overview of the UCB SA/NV large shareholdings will be available = on UCB SA/NV=E2=80=99s website via the following link (https://u7061146.ct.= sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKEbAnX0k1= 68L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM8J= K8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLo= Wbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh-2B4k9FqtM3JLmm2iLomIaFDP9298z= yz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i491Wf3O21vmCMip7QqZatdAotkdFKf1= eNuWm4mPBrjcaxFDY2hdIUpuWMURsQLCrUuJsekdsvX5YBDJtC0KxsBIdS9uI9cJcxC6CfndDNN= J-2FxjWXap9Rb-2BgooBrL-2BUfzJL1aJd0z5ZisgcqqjCXss2ezRrV0-3D . For further information, UCB: Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news =C2=A0 GenericFile 191212-Transparency notification press release Blackrock (https://u7061146.= ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxe= efVm-2FlNugAwKpD5t4i-2B9BeyP9060gEij1cFVVOaBxmrkNElsNlzNlTmhHDKKKdano-3D_-2= B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7= rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh-2B4k9F= qtM3JLmm2iLomIaFDP9298zyz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i491Wf3Eb= jhr4pUnO4YWonP1LvJmFbBUg3W-2B67S-2BM2hTAeT-2FUNYEgjWfF-2Bq9bmscVFwO810bnL3u= Yy8tnloVpbhDlLY3Ny7l-2Bdsg-2FQTiORJVvcFmaz9orjH7BmPyLFMQMqdmnYevul0o00p-2Fh= uhw1ups1tVcI-3D GenericFile 191212- Notification de transparence comm de presse Blackrock (https://u706= 1146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ= 6HnxeefVm-2FlNugAwKpD5t4i-2B9BeIx6vwirQu8-2BCSp4C3wOVzGb8Xetkm2uJGv1B6bGF0R= w-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0h= Txd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh= -2B4k9FqtM3JLmm2iLomIaFDP9298zyz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i4= 91Wf3B6fbdGPcR8yp77KKVY7DoeYQTpL289mu6DsDPKFqUjfz9BkN-2FJO0BtFb1VbEbt6UsXr1= etjQwqYX8KSEMUevc9ByT3u20552zFNAr-2BUfoBfC-2Bkwzy4V9MJeLGN0S4BituUZWkxxb0y3= 6-2FbECyWkCfE-3D GenericFile 191212- Transparantieverklaring persbericht BlackRock (https://u7061146.ct.= sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6HnxeefV= m-2FlNugAwKpD5t4i-2B9BekHAgj4icfGdCVHccuZS00CNLqGk04LR-2F3A9Z94ulkmE-3D_-2B= -2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7r= BLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2BmiCzhY-2Bvh-2B4k9Fq= tM3JLmm2iLomIaFDP9298zyz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19ditFRNgES49i491Wf3Ek3= evahapiHs2woTeEtvDCK-2B4lMUQqa2UM-2BD8-2F-2B-2FYQXROEJo24Lwat3xJkSoTVL1zh3O= nWC8wwH2V8cWgVX6KD4Pkk2d7TtESXSFXG8fqFHw9fgN0-2BXG6ZerSQxaZxTUtK7jmBYjAiELv= NdZauI6tg-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ= Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mr7BdJANyNaxya8ksQLlQNIV08K= W-2FuHATIZj1qS0TtKzGSGDs-2Fu-2F8bIBSI1Q6gQE6Wlf96dH90KmjnoJSLUBPbgqR1Z8ha0s= K6hrmxTL6G3yY-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZT= jzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsABhCwOi7d4h16yQnyNQ-2F-2= BmiCzhY-2Bvh-2B4k9FqtM3JLmm2iLomIaFDP9298zyz9FUG7L0nZ4BqKFwZ4j0iQgpBocOW19d= itFRNgES49i491Wf3OcHjd-2F-2ByFSqBE88JOxvLGRCfDnwHQOqNtLk3xys6rLvGUGZC8OHaA-= 2BWhYA75OxwTzohYrUWfcDV2bZjaEUdhZuRpAu95KyXsINdwFsBKwyfwqshfMxG1N777amBmsfE= myO0MBlWpc8C6v5Vp-2FnBl98-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

24/02/2020 20:00
20/02/2020 07:00
14/02/2020 20:01
10/02/2020 20:00
31/01/2020 20:01
28/01/2020 07:01
27/01/2020 20:00
20/01/2020 20:10
20/01/2020 20:05
20/01/2020 20:01